MS Centrum ErasMS, Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Department of Biostatistics, Erasmus MC, Rotterdam, The Netherlands.
Mult Scler. 2018 Jun;24(7):974-981. doi: 10.1177/1352458517709348. Epub 2017 May 23.
Fatigue is reported by more than 75% of multiple sclerosis (MS) patients. In an earlier study, we showed that fatigue is not only a common symptom in patients at time of clinically isolated syndrome (CIS; fatigued 46%) but also predicts subsequent diagnosis of clinically definite multiple sclerosis (CDMS). The course of fatigue after CIS is unknown.
We aimed to explore the long-term course of fatigue after CIS.
In this study, 235 CIS patients, aged 18-50 years, were prospectively followed. Patients filled in the Krupp's Fatigue Severity Scale (FSS) and the Hospital Anxiety and Depression Scale (HADS) at baseline and annually. After reaching CDMS diagnosis, Expanded Disability Status Scale (EDSS) was obtained annually. Mixed-effects models were used to analyse longitudinal FSS measurements.
Fatigue at baseline was an independent predictor for CDMS diagnosis (hazard ratio (HR): 2.6, 95% confidence interval (CI): 1.6-4.4). The evolution of FSS was the same in CIS patients who remained monophasic and patients who were diagnosed with CDMS during follow-up. However, FSS increased by 0.86 units after reaching CDMS diagnosis ( p = 0.01). After this increase, the FSS course remained unaltered ( p = 0.44).
Fatigue, which is often present at time of CIS, probably persists over time and increases after a second attack.
超过 75%的多发性硬化症 (MS) 患者会出现疲劳。在早期的一项研究中,我们发现疲劳不仅是临床孤立综合征 (CIS;疲劳患者占 46%) 患者的常见症状,而且还可以预测随后的临床确诊多发性硬化症 (CDMS)。CIS 后疲劳的病程尚不清楚。
我们旨在探索 CIS 后疲劳的长期病程。
本研究前瞻性随访了 235 名年龄在 18-50 岁之间的 CIS 患者。患者在基线和每年填写 Krupp 疲劳严重程度量表 (FSS) 和医院焦虑和抑郁量表 (HADS)。达到 CDMS 诊断后,每年获取扩展残疾状态量表 (EDSS)。使用混合效应模型分析纵向 FSS 测量结果。
基线时的疲劳是 CDMS 诊断的独立预测因素 (危险比 (HR):2.6,95%置信区间 (CI):1.6-4.4)。在随访期间保持单相的 CIS 患者和被诊断为 CDMS 的患者的 FSS 演变相同。然而,达到 CDMS 诊断后 FSS 增加了 0.86 单位 ( p = 0.01)。在此增加后,FSS 病程保持不变 ( p = 0.44)。
CIS 时经常出现的疲劳可能会随着时间的推移而持续存在,并在第二次发作后增加。